Literature DB >> 1188839

Electroimmunoassay of factor IX in hemophilia B.

K H Orstavik, B Osterud, H Prydz, K Berg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1188839     DOI： 10.1016/0049-3848(75)90031-6

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  8 in total

1.  Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation.

Authors:  B Osterud; S I Rapaport
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

2.  Factor VIII and factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level.

Authors:  K H Orstavik; P Magnus; H Reisner; K Berg; J B Graham; W Nance
Journal:  Am J Hum Genet       Date:  1985-01       Impact factor: 11.025

3.  Further studies on factor IX antigen in hemophilia B.

Authors:  A Girolami; A Burul; G Cappellato
Journal:  Blut       Date:  1978-10-13

4.  Hemophilia B with associated factor VII deficiency: a distinct variant of hemophilia B with low factor VII activity and normal factor VII antigen.

Authors:  A Girolami; R Dal Bo Zanon; L De Marco; G Cappellato
Journal:  Blut       Date:  1980-04

5.  Incidence, significance, and subtypes of hemophilia BM in a large population of hemophilia B patients.

Authors:  A Girolami; R Dal Bo Zanon; P Saltarin; V Quaino; G Altinier; T Ripa; A Marchetti; D Stocco
Journal:  Blut       Date:  1982-01

6.  Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII.

Authors:  U Seligsohn; B Osterud; S F Brown; J H Griffin; S I Rapaport
Journal:  J Clin Invest       Date:  1979-10       Impact factor: 14.808

7.  Purification and characterization of an abnormal factor IX (Christmas factor) molecule. Factor IX Chapel Hill.

Authors:  K S Chung; D A Madar; J C Goldsmith; H S Kingdon; H R Roberts
Journal:  J Clin Invest       Date:  1978-11       Impact factor: 14.808

8.  Factor IX antigen by radioimmunoassay. Abnormal factor IX protein in patients on warfarin therapy and with hemophilia B.

Authors:  A R Thompson
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.